Shalby Limited (NSE:SHALBY)
India · Delayed Price · Currency is INR | Market Cap | 12.39B -53.4% |
| Revenue (ttm) | 11.76B +6.5% |
| Net Income | 393.11M |
| EPS | 3.51 |
| Shares Out | 107.52M |
| PE Ratio | 33.02 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 243,034 |
| Open | 120.58 |
| Previous Close | 120.58 |
| Day's Range | 114.20 - 122.98 |
| 52-Week Range | 114.20 - 253.00 |
| Beta | 0.61 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |
About Shalby
Shalby Limited operates a chain of multi-specialty hospitals in India and internationally. The company operates through Healthcare Services and Manufacturing segments. It offers rheumatology, knee and hip joint replacement, spine surgery, Paediatric orthopedic and trauma, arthroscopy, and arthroplasty; cardiothoracic and vascular surgery, coronary angiography, angioplasty and stenting, and cardiology services; root canal treatment, dental implants, crowns bridges, dentures, orthodontic treatment, dental cosmetic, teeth whitening, pediatric dent... [Read more]
Financial Performance
In fiscal year 2026, Shalby's revenue was 11.41 billion, an increase of 5.01% compared to the previous year's 10.87 billion. Earnings were 373.88 million, an increase of 500.90%.
Financial StatementsNews
Shalby inaugurates oncology department with advanced radiotherapy in Surat hospital
Shalby has announced the inauguration of its new Oncology Department, complete with advanced radiotherapy facilities, at Shalby Multi-Specialty Hospital in Surat. This development aims to provide comp...
Shalby signs MoU with Bhartiya Skill Development University to launch B.Voc programs in healthcare
Shalby Ltd., through its academic arm Shalby Academy, has announced a new partnership with Bhartiya Skill Development University (BSDU), Jaipur to jointly launch Bachelor of Vocation (B.Voc.) programs...
Shalby shares drop over 2% as Q1 net profit falls 43% YoY to Rs 8.9 crore, Ebitda down 8% YoY
Shalby shares witnessed a decline of over 2% in early trading after the company reported its Q1 results, reflecting a mixed performance in the first quarter of the year. As of 10:11 AM, the shares wer...
Shalby shares drop 4% as EBITDA falls 20.1% YoY in Q3
Shalby Ltd. saw a 4% decline in its stock price following the release of its Q3 results. AS of 10:53 AM, the shares were trading 4.57% lower at Rs 208.81. The company reported a revenue growth of 27.6...
Shalby shares jump 3% after FDA approval for Duraniom knee replacement device
Shalby’s stock jumped 3% following the announcement that its U.S. subsidiary, Shalby Advanced Technologies (SAT) Inc., received FDA 510(k) Premarket Notification Clearance for its Duraniom™ knee repla...